Immunovia AB (publ)

Immunovia AB (publ)verified

IMMNOV.ST

Price:

$0.3405

Market Cap:

$104.22M

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Industry

Medical - Diagnostics & Research

IPO Date

2015-12-01

Stock Exchange

STO

Ticker

IMMNOV.ST

The PE Ratio as of May 2025 (TTM) for Immunovia AB (publ) (IMMNOV.ST) is -0.31

According to Immunovia AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -0.31. This represents a change of -274.10% compared to the average of 0.18 of the last 4 quarters.

Immunovia AB (publ) (IMMNOV.ST) Historical PE Ratio (quarterly & annually)

How has IMMNOV.ST PE Ratio performed in the past?

The mean historical PE Ratio of Immunovia AB (publ) over the last ten years is -27.35. The current -0.31 PE Ratio has changed 13.33% with respect to the historical average. Over the past ten years (40 quarters), IMMNOV.ST's PE Ratio was at its highest in in the December 2024 quarter at 7.55. The PE Ratio was at its lowest in in the June 2016 quarter at -85.25.

Quarterly (TTM)
Annual

Average

-27.35

Median

-23.97

Minimum

-93.64

Maximum

-0.22

Immunovia AB (publ) (IMMNOV.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immunovia AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 164.64%

Maximum Annual PE Ratio = -0.22

Minimum Annual Increase = -94.57%

Minimum Annual PE Ratio = -93.64

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.59164.64%
2023-0.22-94.57%
2022-4.10-61.94%
2021-10.78-37.49%
2020-17.25-43.79%
2019-30.69-0.41%
2018-30.82-6.19%
2017-32.85-64.92%
2016-93.6478.01%
2015-52.6042.04%

Immunovia AB (publ) (IMMNOV.ST) Average PE Ratio

How has IMMNOV.ST PE Ratio performed in the past?

The current PE Ratio of Immunovia AB (publ) (IMMNOV.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.64

5-year avg

-6.59

10-year avg

-27.35

Immunovia AB (publ) (IMMNOV.ST) PE Ratio vs. Peers

How is IMMNOV.ST’s PE Ratio compared to its peers?

Immunovia AB (publ)’s PE Ratio is greater than Oncopeptides AB (publ) (-1.50), greater than Hansa Biopharma AB (publ) (-2.59), greater than Cantargia AB (publ) (-1.81), less than Camurus AB (publ) (69.55), greater than Calliditas Therapeutics AB (publ) (-23.25),

Build a custom stock screener for Immunovia AB (publ) (IMMNOV.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunovia AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunovia AB (publ) (IMMNOV.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunovia AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Immunovia AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Immunovia AB (publ) (IMMNOV.ST)?

What is the highest PE Ratio for Immunovia AB (publ) (IMMNOV.ST)?

What is the 3-year average PE Ratio for Immunovia AB (publ) (IMMNOV.ST)?

What is the 5-year average PE Ratio for Immunovia AB (publ) (IMMNOV.ST)?

How does the current PE Ratio for Immunovia AB (publ) (IMMNOV.ST) compare to its historical average?